Shares of Itron, Inc. (NASDAQ:ITRI) have earned a consensus rating of “Hold” from the twelve analysts that are currently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $77.00.

A number of research analysts have recently weighed in on the company. Raymond James cut their price objective on Itron from $82.00 to $78.00 and set an “outperform” rating on the stock in a report on Tuesday, August 4th. BidaskClub lowered Itron from a “hold” rating to a “sell” rating in a report on Friday, August 28th. Wolfe Research assumed coverage on Itron in a report on Tuesday, August 25th. They issued an “underperform” rating and a $56.00 price objective on the stock. Oppenheimer assumed coverage on Itron in a report on Tuesday, August 11th. They issued a “buy” rating and a $75.00 price objective on the stock. Finally, Canaccord Genuity reissued a “buy” rating on shares of Itron in a report on Thursday, June 18th.

Shares of NASDAQ:ITRI opened at $56.23 on Monday. The business’s 50-day moving average is $61.39 and its 200 day moving average is $63.10. Itron has a 1 year low of $40.48 and a 1 year high of $88.32. The firm has a market capitalization of $2.27 billion, a P/E ratio of -98.65, a P/E/G ratio of 1.90 and a beta of 1.20. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.25 and a quick ratio of 1.88.

Itron (NASDAQ:ITRI) last announced its earnings results on Monday, August 3rd. The scientific and technical instruments company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.20) by $0.23. Itron had a positive return on equity of 11.97% and a negative net margin of 0.96%. The company had revenue of $510.00 million for the quarter, compared to analyst estimates of $486.65 million. During the same period in the prior year, the company posted $0.87 EPS. The firm’s quarterly revenue was down 19.7% compared to the same quarter last year. On average, analysts expect that Itron will post 1.21 EPS for the current year.

In other Itron news, SVP Donald L. Reeves III sold 379 shares of the stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $66.60, for a total transaction of $25,241.40. Following the transaction, the senior vice president now owns 5,450 shares in the company, valued at $362,970. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas Deitrich sold 2,691 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $55.92, for a total value of $150,480.72. Following the transaction, the chief executive officer now owns 143,616 shares in the company, valued at approximately $8,031,006.72. The disclosure for this sale can be found here. Insiders sold 4,156 shares of company stock worth $243,338 in the last 90 days. Company insiders own 1.72% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC lifted its position in shares of Itron by 1.4% in the second quarter. AQR Capital Management LLC now owns 12,164 shares of the scientific and technical instruments company’s stock valued at $806,000 after acquiring an additional 166 shares in the last quarter. Banque Cantonale Vaudoise lifted its position in shares of Itron by 9.3% in the second quarter. Banque Cantonale Vaudoise now owns 1,960 shares of the scientific and technical instruments company’s stock valued at $130,000 after acquiring an additional 167 shares in the last quarter. Putnam FL Investment Management Co. lifted its position in shares of Itron by 1.4% in the second quarter. Putnam FL Investment Management Co. now owns 13,915 shares of the scientific and technical instruments company’s stock valued at $922,000 after acquiring an additional 193 shares in the last quarter. Advisor Group Holdings Inc. lifted its position in shares of Itron by 5.4% in the second quarter. Advisor Group Holdings Inc. now owns 3,783 shares of the scientific and technical instruments company’s stock valued at $250,000 after acquiring an additional 193 shares in the last quarter. Finally, Arizona State Retirement System lifted its position in shares of Itron by 2.5% in the second quarter. Arizona State Retirement System now owns 8,567 shares of the scientific and technical instruments company’s stock valued at $568,000 after acquiring an additional 207 shares in the last quarter. Institutional investors and hedge funds own 95.95% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Featured Story: Stock Symbols Definition, Examples, Lookup

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.